William P. Sheridan, Chief Medical Officer at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 255,387 shares at $15.00 ($3.8M) on 2021-05-27, disclosed to the SEC on 2021-06-01.
Open-market sale of $3.8M BCRX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 71,759 | $1.1M | 28.1% |
| 2 | $15.02 | 91,814 | $1.4M | 36.0% |
| 3 | $15.02 | 91,814 | $1.4M | 36.0% |
| Total | $15.01 avg | 255,387 | $3.8M | 100% |
| Filing → |
| BCRX | SELL | 2018-12-20 | $311K | — | Filing → |
| BCRX | SELL | 2018-08-13 | $439K | — | Filing → |
| BCRX | SELL | 2018-06-05 | $531K | — | Filing → |